Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.
Open | $120.19 |
Close | $122.25 |
Volume / Avg. | 917.85K / 907.37K |
Day Range | $119.82 - $123.39 |
52 Wk Range | 103.63 - 157.98 |
Market Cap | $12.27B |
P/E Ratio | 36.53 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 2.47% |
Days to Cover | 1.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.
Other companies in Neurocrine Biosciences’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Neurocrine Biosciences has a consensus price target of $162.46.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $121.53 last updated September 13, 2024 at 4:05 PM EDT.
There are no upcoming dividends for Neurocrine Biosciences.
Neurocrine Biosciences’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.